Ledger.Open graph →
SEC Form D · Amendment · filed August 23, 2013

ZetaRx Biosciences, Inc

Offering
$12.0M
Sold
$2.0M
Exemption
—
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

People & firms on this filing (11)

Robert Snukal · Santa Monica, CADirectorD. V. Sharma · Encino, CADirectorWerner F. Wolfen · Los Angeles, CAExec · DirectorDavid A. Dull · Newport Coast, CADirectorKen Mohler · Seattle, WAExecThomas Ray · Naples, FLExec · DirectorA. M. Mixon, Iv · Cleveland, OHDirectorPatrick V. Auletta · Hunting Valley, OHDirectorWilliam M. Weber · Chagrin Falls, OHDirectorCynthia Shumate · Seattle, WAExecKen Mohler · PRINCETON, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗